Mutational signature in colorectal cancer caused by genotoxic pks


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 2020
Historique:
received: 14 09 2019
accepted: 17 02 2020
pubmed: 28 2 2020
medline: 4 6 2020
entrez: 28 2 2020
Statut: ppublish

Résumé

Various species of the intestinal microbiota have been associated with the development of colorectal cancer

Identifiants

pubmed: 32106218
doi: 10.1038/s41586-020-2080-8
pii: 10.1038/s41586-020-2080-8
pmc: PMC8142898
mid: NIHMS1694473
doi:

Substances chimiques

Peptides 0
Polyketides 0
colibactin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

269-273

Subventions

Organisme : Cancer Research UK
ID : 27140
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/M009203/1
Pays : United Kingdom
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK115728
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK069989
Pays : United States
Organisme : Medical Research Council
ID : MR/M009203/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_14089
Pays : United Kingdom
Organisme : NIH HHS
ID : 1R01DK115728-01A1
Pays : United States

Investigateurs

J C Ambrose (JC)
P Arumugam (P)
E L Baple (EL)
M Bleda (M)
F Boardman-Pretty (F)
J M Boissiere (JM)
C R Boustred (CR)
H Brittain (H)
M J Caulfield (MJ)
G C Chan (GC)
C E H Craig (CEH)
L C Daugherty (LC)
A de Burca (A)
A Devereau (A)
G Elgar (G)
R E Foulger (RE)
T Fowler (T)
P Furió-Tarí (P)
J M Hackett (JM)
D Halai (D)
A Hamblin (A)
S Henderson (S)
J E Holman (JE)
T J P Hubbard (TJP)
K Ibáñez (K)
R Jackson (R)
L J Jones (LJ)
D Kasperaviciute (D)
M Kayikci (M)
L Lahnstein (L)
L Lawson (L)
S E A Leigh (SEA)
I U S Leong (IUS)
F J Lopez (FJ)
F Maleady-Crowe (F)
J Mason (J)
E M McDonagh (EM)
L Moutsianas (L)
M Mueller (M)
N Murugaesu (N)
A C Need (AC)
C A Odhams (CA)
C Patch (C)
D Perez-Gil (D)
D Polychronopoulos (D)
J Pullinger (J)
T Rahim (T)
A Rendon (A)
P Riesgo-Ferreiro (P)
T Rogers (T)
M Ryten (M)
K Savage (K)
K Sawant (K)
R H Scott (RH)
A Siddiq (A)
A Sieghart (A)
D Smedley (D)
K R Smith (KR)
A Sosinsky (A)
W Spooner (W)
H E Stevens (HE)
A Stuckey (A)
R Sultana (R)
E R A Thomas (ERA)
S R Thompson (SR)
C Tregidgo (C)
A Tucci (A)
E Walsh (E)
S A Watters (SA)
M J Welland (MJ)
E Williams (E)
K Witkowska (K)
S M Wood (SM)
M Zarowiecki (M)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

Allen, J. & Sears, C. L. Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development. Genome Med. 11, 11 (2019).
doi: 10.1186/s13073-019-0621-2
Gagnaire, A., Nadel, B., Raoult, D., Neefjes, J. & Gorvel, J.-P. Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer. Nat. Rev. Microbiol. 15, 109–128 (2017).
doi: 10.1038/nrmicro.2016.171
Nougayrède, J.-P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848–851 (2006).
doi: 10.1126/science.1127059
Wilson, M. R. et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science 363, eaar7785 (2019).
doi: 10.1126/science.aar7785
Xue, M. et al. Structure elucidation of colibactin and its DNA cross-links. Science 365, eaax2685 (2019).
doi: 10.1126/science.aax2685
Dejea, C. M. et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359, 592–597 (2018).
doi: 10.1126/science.aah3648
Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443–1448 (2017).
doi: 10.1126/science.aal5240
Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207–215 (2013).
doi: 10.1016/j.chom.2013.07.007
Wirbel, J. et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 25, 679–689 (2019).
doi: 10.1038/s41591-019-0406-6
Buc, E. et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One 8, e56964 (2013).
doi: 10.1371/journal.pone.0056964
Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120–123 (2012).
doi: 10.1126/science.1224820
Bossuet-Greif, N. et al. The colibactin genotoxin generates DNA interstrand cross-links in infected cells. mBio 9, e02393-17 (2018).
doi: 10.1128/mBio.02393-17
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
doi: 10.1038/s41586-020-1943-3
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
doi: 10.1038/nature12477
Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993 (2012).
doi: 10.1016/j.cell.2012.04.024
Drost, J. et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science 358, 234–238 (2017).
doi: 10.1126/science.aao3130
Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141, 1762–1772 (2011).
doi: 10.1053/j.gastro.2011.07.050
Tuveson, D. & Clevers, H. Cancer modeling meets human organoid technology. Science 364, 952–955 (2019).
doi: 10.1126/science.aaw6985
Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821–836.e16 (2019).
doi: 10.1016/j.cell.2019.03.001
Jager, M. et al. Measuring mutation accumulation in single human adult stem cells by whole-genome sequencing of organoid cultures. Nat. Protocols 13, 59–78 (2018).
doi: 10.1038/nprot.2017.111
Cougnoux, A. et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 63, 1932–1942 (2014).
doi: 10.1136/gutjnl-2013-305257
Bartfeld, S. et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 148, 126–136.e6 (2015).
doi: 10.1053/j.gastro.2014.09.042
Li, Z.-R. et al. Divergent biosynthesis yields a cytotoxic aminomalonate-containing precolibactin. Nat. Chem. Biol. 12, 773–775 (2016).
doi: 10.1038/nchembio.2157
Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210–216 (2019).
doi: 10.1038/s41586-019-1689-y
Gonzalez-Perez, A. et al. IntOGen-mutations identifies cancer drivers across tumor types. Nat. Methods 10, 1081–1082 (2013).
doi: 10.1038/nmeth.2642
Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532–537 (2019).
doi: 10.1038/s41586-019-1672-7
McLellan, L. K. & Hunstad, D. A. Urinary tract infection: pathogenesis and outlook. Trends Mol. Med. 22, 946–957 (2016).
doi: 10.1016/j.molmed.2016.09.003
Zawadzki, P. J. et al. Identification of infectious microbiota from oral cavity environment of various population group patients as a preventive approach to human health risk factors. Ann. Agric. Environ. Med. 23, 566–569 (2016).
doi: 10.5604/12321966.1226847
Banerjee, S. et al. Microbial signatures associated with oropharyngeal and oral squamous cell carcinomas. Sci. Rep. 7, 4036 (2017).
doi: 10.1038/s41598-017-03466-6
Boot, A. et al. Identification of novel mutational signatures in Asian oral squamous cell carcinomas associated with bacterial infections Preprint at https://doi.org/10.1101/368753 (2019).
Payros, D. et al. Maternally acquired genotoxic Escherichia coli alters offspring’s intestinal homeostasis. Gut Microbes 5, 313–325 (2014).
doi: 10.4161/gmic.28932
Olier, M. et al. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes 3, 501–509 (2012).
doi: 10.4161/gmic.21737
Jacobi, C. A. & Malfertheiner, P. Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium. Dig. Dis. 29, 600–607 (2011).
doi: 10.1159/000333307
Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260–264 (2016).
doi: 10.1038/nature19768
Heo, I. et al. Modelling Cryptosporidium infection in human small intestinal and lung organoids. Nat. Microbiol. 3, 814–823 (2018).
doi: 10.1038/s41564-018-0177-8
Pace, P. et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21, 3414–3423 (2002).
doi: 10.1093/emboj/cdf355
Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).
doi: 10.1093/bioinformatics/btp698
Osorio, F. G. et al. Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis. Cell Rep. 25, 2308–2316.e4 (2018).
doi: 10.1016/j.celrep.2018.11.014
Blokzijl, F., Janssen, R., van Boxtel, R. & Cuppen, E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. 10, 33 (2018).
doi: 10.1186/s13073-018-0539-0
Cunningham, F. et al. Ensembl 2015. Nucleic Acids Res. 43, D662–D669 (2015).
Cameron, D. L. et al. GRIDSS, PURPLE, LINX: unscrambling the tumor genome via integrated analysis of structural variation and copy number. Preprint at https://doi.org/10.1101/781013 (2019).
Genomics England The National Genomics Research and Healthcare Knowledgebase https://www.genomicsengland.co.uk/the-national-genomics-research-and-healthcare-knowledgebase/ (2017).
Raczy, C. et al. Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms. Bioinformatics 29, 2041–2043 (2013).
doi: 10.1093/bioinformatics/btt314
Lawrence, M. et al. Software for computing and annotating genomic ranges. PLOS Comput. Biol. 9, e1003118 (2013).
doi: 10.1371/journal.pcbi.1003118

Auteurs

Cayetano Pleguezuelos-Manzano (C)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Jens Puschhof (J)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Axel Rosendahl Huber (A)

Oncode Institute, Utrecht, The Netherlands.
The Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Arne van Hoeck (A)

Oncode Institute, Utrecht, The Netherlands.
Center for Molecular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.

Henry M Wood (HM)

Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.

Jason Nomburg (J)

Graduate Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Carino Gurjao (C)

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Freek Manders (F)

Oncode Institute, Utrecht, The Netherlands.
The Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Guillaume Dalmasso (G)

University Clermont Auvergne, Inserm U1071, INRA USC2018, M2iSH, Clermont-Ferrand, France.

Paul B Stege (PB)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Fernanda L Paganelli (FL)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Maarten H Geurts (MH)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Joep Beumer (J)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.

Tomohiro Mizutani (T)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Yi Miao (Y)

Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA.
Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.

Reinier van der Linden (R)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.

Stefan van der Elst (S)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.

K Christopher Garcia (KC)

Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA.
Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.

Janetta Top (J)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Rob J L Willems (RJL)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Marios Giannakis (M)

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Richard Bonnet (R)

University Clermont Auvergne, Inserm U1071, INRA USC2018, M2iSH, Clermont-Ferrand, France.
Department of Bacteriology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.

Phil Quirke (P)

Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.

Matthew Meyerson (M)

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Genetics, Harvard Medical School, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Edwin Cuppen (E)

Oncode Institute, Utrecht, The Netherlands.
Center for Molecular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
Hartwig Medical Foundation, Amsterdam, The Netherlands.
CPCT Consortium, Rotterdam, The Netherlands.

Ruben van Boxtel (R)

Oncode Institute, Utrecht, The Netherlands. R.vanBoxtel@prinsesmaximacentrum.nl.
The Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. R.vanBoxtel@prinsesmaximacentrum.nl.

Hans Clevers (H)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands. h.clevers@hubrecht.eu.
Oncode Institute, Utrecht, The Netherlands. h.clevers@hubrecht.eu.
The Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. h.clevers@hubrecht.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH